Company profile: DeepUll
1.1 - Company Overview
Company description
- Provider of a biotech diagnostic system for early-stage sepsis that rapidly identifies pathogens and delivers an antibiogram within hours, leveraging patient immunological and functional data.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DeepUll
Meretek Diagnostics
HQ: United States
Website
- Description: Provider of non-invasive, non-radioactive breath tests and instruments for diagnostic applications, offering BreathTek UBT and BreathTek-UBiT collection kits for qualitative detection of urease associated with Helicobacter pylori in the human stomach, supporting initial diagnosis and post-treatment monitoring of Helicobacter pylori infection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meretek Diagnostics company profile →
Karius
HQ: United States
Website
- Description: Provider of genomic insights into infectious diseases via the Karius Test, a liquid biopsy detecting over 1,000 pathogens from a single blood sample for rapid, non-invasive diagnosis. Offers microbial cell-free DNA detection, AI-driven real-time analysis against proprietary reference genome databases, and clinical and analytical validation, helping clinicians make critical, life-saving treatment decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Karius company profile →
Scynexis
HQ: United States
Website
- Description: Provider of drug discovery, development and manufacturing projects focused on antifungal therapeutics, including ibrexafungerp, a novel oral/IV glucan synthase inhibitor for serious and resistant fungal infections; SCY-247, a second-generation broad-spectrum triterpenoid; VVC and RVVC treatments; and the MARIO study evaluating oral step-down after IV echinocandin for invasive candidiasis and candidemia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scynexis company profile →
Micropharma
HQ: Canada
Website
- Description: Provider of biotherapeutics, diagnostics, and devices for metabolic diseases, discovering and developing bacteria-based biotherapeutics and novel probiotic and enzymatic solutions through a unique approach from basic research to product development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micropharma company profile →
Venatorx Pharmaceuticals
HQ: United States
Website
- Description: Provider of anti-infective therapies for multi-drug-resistant bacterial and viral infections, including cefepime-taniborbactam for complicated urinary tract infections and potentially hospital-acquired and ventilator-associated bacterial pneumonia; ceftibuten-ledaborbactam etzadroxil for drug-resistant Enterobacterales; and a PBP inhibitor program developing non-beta-lactam molecules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Venatorx Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DeepUll
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DeepUll
2.2 - Growth funds investing in similar companies to DeepUll
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DeepUll
4.2 - Public trading comparable groups for DeepUll
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →